What do we know about the Arcturus XBB.1.16 subvariant?

Article covers this new line of omicron subvariants first reported in India in Jan 2023. It is currently at a low prevalence in the UK, but showing early evidence of growth advantage. Current signs suggest no increased disease severity. There are no data on vaccine efficacy.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news